Link to this page
Medical Subject Headings
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/MESH/D000080045
http://purl.bioontology.org/ontology/MESH/D000080045
|
|---|---|
| Preferred Name | Inotuzumab Ozogamicin |
| Definitions |
Immunotoxin that consists of anti-CD22 (CD22 ANTIGEN) humanized monoclonal antibody covalently linked to the antineoplastic antibiotic CALICHEAMICIN. It is used for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (LEUKEMIA, ACUTE LYMPHOBLASTIC).
|
| Synonyms |
CMC 544
CMC-544
CMC544
Besponsa
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | Immunotoxin that consists of anti-CD22 (CD22 ANTIGEN) humanized monoclonal antibody covalently linked to the antineoplastic antibiotic CALICHEAMICIN. It is used for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (LEUKEMIA, ACUTE LYMPHOBLASTIC). |
|---|---|
| altLabel |
CMC 544
CMC-544
CMC544
Besponsa
|
| prefLabel | Inotuzumab Ozogamicin
|
| Machine permutation | 2020; INOTUZUMAB OZOGAMICIN was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2012-2019 and under ANTIBODIES, MONOCLONAL (2004-2011)
|
| HN | 2020 (2004)
|
| type | |
| isa | |
| PA |
D000074322
D000922
D000903
|
| tui |
T116
T129
T121
|
| TERMUI |
T000949644
T567154
T634605
T567153
|
| TH |
NLM (2004)
NLM (2005)
NLM (2020)
FDA SRS (2017)
USAN (19XX)
INN (19XX)
See more
See less
|
| MMR | 20200101
|
| notation | D000080045
|
| Semantic type UMLS property | |
| Inverse of AQ |
See more
See less
|
| DX | 20200101
|
| cui |
C4520189
C1328139
C1567130
|
| DC | 1
|
| MN |
D12.776.124.486.485.114.224.060.794
D09.408.051.247.750
D12.776.377.715.548.114.224.200.794
D12.776.124.790.651.114.224.060.794
|
| LT | TRD
|
| AQL | AD AE AN BL CF CH CL DE EC GE HI IM IP ME PD PK PO RE TO TU UL UR
|
| Inverse of RB |
P93RUU11P7
0
|
| MDA | 20050328
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |